Apyx Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	-18.71	-23.18	-15.17	-11.9	-19.71	62.72	-5.06	-3.95	8.36	-18.21	Upgrade
Depreciation & Amortization	0.78	0.89	0.9	0.89	0.75	0.67	0.7	0.73	0.81	0.88	Upgrade
Share-Based Compensation	5.11	6.7	5.09	4.21	3.58	2.22	0.87	0.81	0.58	0.39	Upgrade
Other Operating Activities	7.57	-4.68	-1.27	-9.27	-3.1	-86.49	-0.21	-0.43	-15.76	15.6	Upgrade
Operating Cash Flow	-5.25	-20.28	-10.45	-16.07	-18.48	-20.88	-3.7	-2.84	-5.79	-0.42	Upgrade
Capital Expenditures	6.73	-1.01	-0.72	-0.58	-1.3	-0.36	-0.62	-0.29	-0.42	-0.63	Upgrade
Acquisitions	0	0	0	0	0	91.1	0	0	-0.5	0	Upgrade
Change in Investments	0	0	0	0	61.84	-61.43	0	0	0	0	Upgrade
Investing Cash Flow	6.73	-1.01	-0.72	-0.58	60.54	29.3	-0.62	-0.29	-0.92	-0.63	Upgrade
Share Issuance / Repurchase	0.09	0.37	0.07	0.15	0.21	0.2	0	5.95	12.96	0.26	Upgrade
Debt Issued / Paid	31.93	-0.15	-0.24	-0.37	-0.06	-2.69	-0.24	-0.24	-0.24	-0.08	Upgrade
Other Financing Activities	0.15	-	0.2	0.15	-	-	-	-	0.06	-1.32	Upgrade
Financing Cash Flow	32.17	0.22	0.02	-0.07	0.15	-2.49	-0.24	5.71	12.78	-1.14	Upgrade
Exchange Rate Effect	-0.19	0.4	0.1	-0.18	0	0	0	0	0	0	Upgrade
Net Cash Flow	33.46	-20.68	-11.05	-16.9	42.22	5.93	-4.57	2.59	6.07	-2.19	Upgrade
Free Cash Flow	1.49	-21.29	-11.17	-16.65	-19.78	-21.24	-4.33	-3.12	-6.21	-1.05	Upgrade
Free Cash Flow Margin	2.84%	-47.83%	-23.03%	-60.07%	-70.04%	-127.94%	-42.29%	-35.41%	-21.03%	-3.78%	Upgrade
Free Cash Flow Per Share	0.04	-0.62	-0.33	-0.49	-0.58	-0.64	-0.14	-0.11	-0.26	-0.06	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).